117 related articles for article (PubMed ID: 22823061)
1. p27(Kip1) V109G polymorphism and cancer risk: a systematic review and meta-analysis.
Wei F; Xu J; Tang L; Shao J; Wang Y; Chen L; Guan X
Cancer Biother Radiopharm; 2012 Dec; 27(10):665-71. PubMed ID: 22823061
[TBL] [Abstract][Full Text] [Related]
2.
Zhang M; Liang Q; Zhang L; Hao Z; Zhou J; Zhang L; Fan S; Liang C
Dis Markers; 2018; 2018():1418609. PubMed ID: 29750086
[TBL] [Abstract][Full Text] [Related]
3. Genetic association between the cyclin-dependent kinase inhibitor gene p27/Kip1 polymorphism (rs34330) and cancer susceptibility: a meta-analysis.
Cheng XK; Wang XJ; Li XD; Ren XQ
Sci Rep; 2017 Mar; 7():44871. PubMed ID: 28317869
[TBL] [Abstract][Full Text] [Related]
4. [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Guo W; Cui YJ; Fang SM; Li Y; Wang N; Zhang JH
Ai Zheng; 2006 Feb; 25(2):194-9. PubMed ID: 16480585
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
Circelli L; Ramundo V; Marotta V; Sciammarella C; Marciello F; Del Prete M; Sabatino L; Pasquali D; Izzo F; Scala S; Colao A; Faggiano A; Colantuoni V;
J Cell Mol Med; 2015 Jul; 19(7):1735-41. PubMed ID: 25824098
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.
Sergentanis TN; Economopoulos KP
Mol Biol Rep; 2011 Nov; 38(8):4955-63. PubMed ID: 21161398
[TBL] [Abstract][Full Text] [Related]
7. Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.
Landa I; Montero-Conde C; Malanga D; De Gisi S; Pita G; Leandro-García LJ; Inglada-Pérez L; Letón R; De Marco C; Rodríguez-Antona C; Viglietto G; Robledo M
Endocr Relat Cancer; 2010 Jun; 17(2):317-28. PubMed ID: 20075119
[TBL] [Abstract][Full Text] [Related]
8. Genetic Association Between CDKN1B rs2066827 Polymorphism and Susceptibility to Cancer.
Lu Y; Gao K; Zhang M; Zhou A; Zhou X; Guan Z; Shi X; Ge S
Medicine (Baltimore); 2015 Nov; 94(46):e1217. PubMed ID: 26579796
[TBL] [Abstract][Full Text] [Related]
9. Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.
Chen MB; Li C; Shen WX; Guo YJ; Shen W; Lu PH
Mol Biol Rep; 2011 Oct; 38(7):4687-95. PubMed ID: 21127985
[TBL] [Abstract][Full Text] [Related]
10. The V109G polymorphism in the p27 gene is associated with endometriosis.
Camargo-Kosugi CM; da Silva ID; Sato H; D'Amora P; Carvalho CV; Nogueira-de-Souza NC; Girão MJ; Schor E
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):180-3. PubMed ID: 19493606
[TBL] [Abstract][Full Text] [Related]
11. HLA-G +3142 C>G polymorphism and cancer risk: Evidence from a meta-analysis and trial sequential analysis.
Jiang Y; Li W; Lu J; Zhao X; Li L
Medicine (Baltimore); 2019 Jun; 98(25):e16067. PubMed ID: 31232944
[TBL] [Abstract][Full Text] [Related]
12. The prognostic of p27(kip1) in ovarian cancer: a meta-analysis.
Lu M; Wang Y; Xu F; Xiang J; Chen D
Arch Gynecol Obstet; 2016 Jan; 293(1):169-176. PubMed ID: 26198169
[TBL] [Abstract][Full Text] [Related]
13. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
Naidu R; Har YC; Taib NA
J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
[TBL] [Abstract][Full Text] [Related]
14. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
15. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
Jin X; Kang S; Wang N; Xing YP; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between cyclin-dependent kinase inhibitor 1B rs2066827 polymorphism and breast cancer susceptibility.
Jia ZM; Liu Y; Cui SY
Tumour Biol; 2014 Jun; 35(6):5527-31. PubMed ID: 24523023
[TBL] [Abstract][Full Text] [Related]
17. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies.
Diakite B; Kassogue Y; Dolo G; Wang J; Neuschler E; Kassogue O; Keita ML; Traore CB; Kamate B; Dembele E; Nadifi S; Murphy RL; Doumbia S; Hou L; Maiga M
BMC Med Genet; 2020 Oct; 21(1):206. PubMed ID: 33076844
[TBL] [Abstract][Full Text] [Related]
18. Association of tumor necrosis factor-α 308G/A polymorphism with urogenital cancer risk: a systematic review and meta-analysis.
Cai J; Yang MY; Hou N; Li X
Genet Mol Res; 2015 Dec; 14(4):16102-12. PubMed ID: 26662402
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
20. A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts.
Conte MS; Owens CD; Belkin M; Creager MA; Edwards KL; Gasper WJ; Kenagy RD; LeBoeuf RC; Sobel M; Clowes A
J Vasc Surg; 2013 May; 57(5):1179-85.e1-2. PubMed ID: 23312942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
